James Edgemond United Therapeutics Corp (UTHR) insider trading activity

UTHR Quotes by TradingView

James Edgemond is CFO AND TREASURER of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 8,142 shares of UTHR, which is worth approximately $3.8 Million. The most recent transaction as insider was on Oct 14, 2024, when has been sold 8,334 shares (Common Stock) at a price of $134.01 per share, resulting in proceeds of $1,116,839. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.14K
0.3% 3M change
0.92% 12M change
Total Value Held $3.8 Million

JAMES EDGEMOND Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 14 2024
BUY
Exercise of conversion of derivative security
$1,116,839 $134.01 p/Share
8,334 Added 54.36%
6,998 Common Stock
Oct 07 2024
SELL
Open market or private sale
$2,771,078 $355.54 p/Share
7,794 Reduced 56.98%
5,884 Common Stock
Oct 07 2024
BUY
Exercise of conversion of derivative security
$991,829 $119.01 p/Share
8,334 Added 56.35%
6,457 Common Stock
Sep 30 2024
SELL
Open market or private sale
$2,794,367 $358.62 p/Share
7,792 Reduced 59.32%
5,344 Common Stock
Sep 30 2024
BUY
Exercise of conversion of derivative security
$991,829 $119.01 p/Share
8,334 Added 58.48%
5,916 Common Stock
Sep 23 2024
SELL
Open market or private sale
$2,760,095 $354.04 p/Share
7,796 Reduced 61.88%
4,802 Common Stock
Sep 23 2024
BUY
Exercise of conversion of derivative security
$991,829 $119.01 p/Share
8,334 Added 60.79%
5,376 Common Stock
Sep 16 2024
SELL
Open market or private sale
$2,648,527 $339.12 p/Share
7,810 Reduced 64.68%
4,264 Common Stock
Sep 16 2024
BUY
Exercise of conversion of derivative security
$991,829 $119.01 p/Share
8,334 Added 63.24%
4,845 Common Stock
Sep 09 2024
SELL
Open market or private sale
$2,694,888 $345.41 p/Share
7,802 Reduced 67.6%
3,740 Common Stock
Sep 09 2024
BUY
Exercise of conversion of derivative security
$991,591 $119.01 p/Share
8,332 Added 65.87%
4,318 Common Stock
Sep 03 2024
SELL
Open market or private sale
$2,821,050 $362.37 p/Share
7,785 Reduced 71.12%
3,162 Common Stock
Sep 03 2024
BUY
Exercise of conversion of derivative security
$991,591 $119.01 p/Share
8,332 Added 69.07%
3,731 Common Stock
Aug 26 2024
SELL
Open market or private sale
$2,710,932 $347.6 p/Share
7,799 Reduced 74.89%
2,615 Common Stock
Aug 26 2024
BUY
Exercise of conversion of derivative security
$991,591 $119.01 p/Share
8,332 Added 72.31%
3,191 Common Stock
Aug 19 2024
SELL
Open market or private sale
$2,575,568 $329.02 p/Share
7,828 Reduced 78.99%
2,082 Common Stock
Aug 19 2024
BUY
Exercise of conversion of derivative security
$991,591 $119.01 p/Share
8,332 Added 75.71%
2,673 Common Stock
May 15 2024
SELL
Open market or private sale
$10,951,230 $272.69 p/Share
40,160 Reduced 96.22%
1,578 Common Stock
May 15 2024
BUY
Exercise of conversion of derivative security
$6,558,128 $163.3 p/Share
40,160 Added 70.58%
16,738 Common Stock
Nov 07 2022
SELL
Sale (or disposition) back to the issuer
$1,977,254 $266.8 p/Share
7,411 Reduced 84.26%
1,384 Common Stock
Nov 07 2022
BUY
Exercise of conversion of derivative security
$545,004 $73.54 p/Share
7,411 Added 66.13%
3,795 Common Stock
JE

James Edgemond

CFO AND TREASURER
Silver Spring, MD

Track Institutional and Insider Activities on UTHR

Follow UNITED THERAPEUTICS Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

News

Receive news related to UNITED THERAPEUTICS Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on UTHR